Skip to main content
OpenTrials
Completed

NCT Number: NCT00131573

An Implantable Microstimulator for the Chronic Treatment of Urinary Urgency-Frequency Syndrome

The goal of this study is to investigate the safety and effectiveness of a new implanted device designed to treat Urinary Urgency-Frequency Syndrome.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 3

Primary location

Arizona Health Sciences Center, Tucson, Arizona, United States

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Key Inclusion criteria:

  • Age 18 years and above.
  • Diagnosed with urinary urgency-frequency syndrome.
  • Have no reported history of urethral obstruction/stricture, bladder calculi or bladder tumor.
  • Have normal upper urinary tract function.
  • Be capable of giving informed consent.
  • Be capable and willing to follow all study related procedures.

Key Exclusion Criteria:

  • Have any active implantable device regardless of whether stimulation status is ON or OFF.
  • Are pregnant as confirmed by a urine pregnancy test or plan to become pregnant during the following 12 month period.
  • Less than one year post partum and/or are breast-feeding.
  • Have any large passive implant that contains metal located within 30 cm of the chair pad while seated (e.g., hip replacement).
  • Have conditions requiring magnetic resonance imaging (MRI) evaluation.
  • Have conditions requiring diathermy procedures.
  • Have an inability to operate the bion Remote Control and bion Recharging System either by self or caregiver.
  • Have diabetes with peripheral nerve involvement or have severe uncontrolled diabetes.
  • Have history of coagulopathy or bleeding disorder.
  • Have pelvic pain in the absence of voiding dysfunction.
  • Have anatomical restrictions such that the study device placement is not possible.
  • Are currently participating or have participated within the past 30 days in any clinical investigation involving or impacting urinary or renal function.
  • Cannot independently comprehend and complete the questionnaires.

Treatment and study plan

BION

Device

battery powered bion microstimulator

Primary outcomes

  1. Average Number of Voids Per Day

    Time frame: 12 months

  2. Freedom From Major Complications

    Time frame: 5 years

Sponsors and collaborators

Lead sponsor

Boston Scientific Corporation

Industry

Registry information

Official study title

Battery Powered Bion Clinical Investigation: Bion - An Implantable Microstimulator for the Chronic Treatment of Refractory Urinary Urgency-Frequency Syndrome

Important dates

Study start
2004
Primary completion
2008
Study completion
2012
First posted
Aug 19, 2005
Registry last updated
Nov 19, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.